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Supplementary Table S1: Average distance between the backbone Cα or the side-chain 
Cβ of G-loop residues in two opposite facing subunits. The standard deviation is an 
indication of the flexibility of the G-loop at the different residues. Distances that exhibit 











G300(Cα-Cα) 19.4 1.2 
M301(Cα-Cα) 17.0 1.3 
M301(Cβ-Cβ) 15.1 1.9 
V302(Cα-Cα) 22.0 1.4 
V302(Cβ-Cβ) 22.6 1.3 
E303(Cα-Cα) 24.1 2.7 
E303(Cβ-Cβ) 26.9 2.9 
A304(Cα-Cα) 24.5 2.7 
A304(Cβ-Cβ) 26.2 2.7 
T305(Cα-Cα) 17.8 2.8 
T305(Cβ-Cβ) 17.7 2.7 
A306(Cα-Cα) 13.0 3.5 
M307(Cα-Cα) 12.9 1.8 
M307(Cβ-Cβ) 14.5 2.3 
T308(Cα-Cα) 14.1 0.9 
T308(Cβ-Cβ) 12.3 0.9 
T309(Cα-Cα) 21.4 1.1 
T309(Cβ-Cβ) 23.3 1.2 
Q310(Cα-Cα) 26.1 1.1 








Supplementary Table S2: Correlations and their significance between the G-loop gating elements of the channel and the cholesterol 
sensitivity belt residues of the N-terminus and the link between the C-terminus and the inner TM helix. R is the correlation, and P is 









K / Q / R 
H53(Cβ-Cβ)/ 






L / M  
V194(Cβ-Cβ)/ 
L / M  
 R P R P R P R P R P R P R P R P 
E303(Cα-Cα) -0.29 0.52 -0.29 0.52 -0.20 0.66 -0.17 0.71 0.41 0.42 -0.03 0.95 -0.39 0.39 -0.98 <10-4 
E303(Cβ-Cβ) -0.31 0.50 -0.31 0.49 -0.23 0.62 -0.20 0.67 0.43 0.40 -0.01 0.99 -0.39 0.39 -0.97 2*10-4 
E303(Oε1/2-Oε1/2)  -0.57 0.18 -0.58 0.17 -0.51 0.25 -0.50 0.25 0.21 0.68 -0.11 0.83 -0.51 0.24 -0.62 0.13 
A304(Cα-Cα) -0.15 0.74 -0.16 0.74 -0.004 0.99 0.09 0.86 0.18 0.73 -0.18 0.74 -0.18 0.70 -0.80 0.03 
A304(Cβ-Cβ) 0.03 0.95 0.038 0.94 0.18 0.70 0.26 0.57 0.05 0.93 -0.31 0.56 -0.16 0.73 -0.76 0.05 
T305(Cα-Cα) -0.04 0.94 -0.01 0.98 0.11 0.82 0.20 0.67 -0.25 0.63 -0.55 0.26 -0.28 0.54 -0.65 0.12 
T305(Cβ-Cβ) 0.23 0.62 0.27 0.56 0.35 0.44 0.42 0.34 -0.54 0.27 -0.73 0.10 -0.22 0.63 -0.43 0.34 
T305(Oγ1-Oγ1) -0.11 0.82 -0.07 0.88 0.39 0.39 0.46 0.30 -0.51 0.29 -0.72 0.11 -0.16 0.73 -0.42 0.35 
A306(Cα-Cα) -0.14 0.73 -0.13 0.76 0.003 0.99 0.11 0.80 0.13 0.81 -0.22 0.67 -0.04 0.92 -0.48 0.22 
M307(Cα-Cα) 0.64 0.08 0.64 0.09 0.69 0.06 0.70 0.05 0.23 0.66 -0.08 0.88 0.23 0.58 -0.56 0.15 
M307(Cβ-Cβ) 0.73 0.04 0.73 0.04 0.73 0.04 0.70 0.05 0.16 0.76 0.13 0.80 0.30 0.46 -0.36 0.38 








Supplementary Table S3: Correlations and their significance between the G-loop gating elements of the channel and the cholesterol 














I / M 
L222(Cβ-Cβ)/





 R P R P R P R P R P R P R P R P 
E303(Cα-Cα) -0.20 0.71 0.86 0.03 -0.02 0.97 -0.35 0.44 0.70 0.08 0.82 0.02 -0.03 0.95 0.001 1.00 
E303(Cβ-Cβ) -0.21 0.68 0.85 0.03 -0.05 0.91 -0.39 0.39 0.71 0.08 0.81 0.03 -0.04 0.93 -0.01 0.98 
E303(Oε1/2-Oε1/2)  -0.52 0.29 0.34 0.50 -0.39 0.44 -0.62 0.19 0.90 0.006 0.66 0.11 -0.35 0.44 -0.31 0.50 
A304(Cα-Cα) 0.07 0.89 0.96 0.003 0.19 0.68 -0.05 0.92 0.57 0.18 0.67 0.10 0.02 0.97 0.04 0.94 
A304(Cβ-Cβ) 0.15 0.77 0.98 2*10-4 0.42 0.35 0.17 0.71 0.43 0.34 0.66 0.10 0.18 0.70 0.16 0.74 
T305(Cα-Cα) 0.04 0.93 0.96 0.003 0.50 0.25 0.27 0.56 0.34 0.46 0.52 0.24 0.05 0.92 -0.02 0.96 
T305(Cβ-Cβ) 0.18 0.73 0.87 0.03 0.77 0.04 0.60 0.16 0.04 0.94 0.38 0.41 0.24 0.60 0.12 0.80 
T305(Oγ1-Oγ1) 0.30 0.57 0.90 0.02 0.81 0.05 0.65 0.16 -0.07 0.88 0.30 0.51 0.28 0.54 0.15 0.74 
A306(Cα-Cα) 0.21 0.64 0.71 0.07 0.22 0.63 -0.02 0.97 0.48 0.28 0.52 0.23 -0.03 0.95 -0.009 0.98 
M307(Cα-Cα) 0.47 0.28 0.77 0.04 0.78 0.06 0.74 0.09 -0.15 0.75 0.45 0.31 0.76 0.03 0.71 0.05 
M307(Cβ-Cβ) 0.48 0.28 0.55 0.20 0.80 0.03 0.72 0.07 -0.50 0.25 0.16 0.73 0.79 0.02 0.73 0.04 






























Supplementary Table S4: Correlations and their significance between the G-loop gating 
elements of the channel and Q57 and N190. R is the correlation, and P is the significance. None 
of the correlations (R) is significant since P>0.05 for all cases. Both Q57 and N190 are just 





E / H 
Q57(Cβ-Cβ)/ 





 R P R P R P R P 
E303(Cα-Cα) 0.56 0.24 0.62 0.19 0.40 0.43 0.43 0.38 
E303(Cβ-Cβ) 0.60 0.21 0.66 0.16 0.43 0.40 0.46 0.36 
E303(Oε1/2-Oε1/2)  0.27 0.61 0.35 0.50 0.26 0.63 0.26 0.62 
A304(Cα-Cα) 0.19 0.72 0.27 0.60 0.14 0.79 0.20 0.71 
A304(Cβ-Cβ) 0.09 0.86 0.17 0.74 0.02 0.97 0.07 0.89 
T305(Cα-Cα) -0.19 0.72 -0.11 0.83 -0.27 0.60 -0.21 0.68 
T305(Cβ-Cβ) -0.45 0.37 -0.39 0.44 -0.54 0.27 -0.48 0.33 
T305(Oγ1-Oγ1) -0.37 0.47 -0.33 0.53 -0.53 0.27 -0.48 0.33 
A306(Cα-Cα) -0.06 0.89 -0.003 0.99 0.06 0.91 0.11 0.84 
M307(Cα-Cα) 0.64 0.12 0.66 0.11 0.17 0.75 0.22 0.68 
M307(Cβ-Cβ) 0.65 0.12 0.62 0.13 0.11 0.84 0.13 0.80 
M307(Sδ-Sδ) -0.67 0.15 -0.74 0.09 -0.72 0.10 -0.72 0.10 
  
 
Figure Captions for Supplementary Figures   
 
Supplemental Figure S1:  
Alignment of sequences of the cytosolic domains of modeled Kir2.1 and Kir2.3 channels. 
 
Supplemental Figure S2:  
Representative traces of whole-cell basal currents recorded at –80mV/+80mV in Xenopus 
oocytes showing the effect of cholesterol enrichment on Kir2.1, and the mutants D51N, H53Q, 
N190A, E191Q, V194L, and C311A. The waveform and the scale are shown in the bottom left 
corner of the figure. The black traces were obtained following application of HK solution, and 
the red curves were obtained when BaCl2 is added to the HK solution (See Methods). 
 
Supplemental Figure S3:  
A. Plot of each of the residues in the modeled cytosolic domain of the channel and the lower TM 
domain and the percentage of poses in which they appeared. B. The similarity (in percentage) 
between each of the 135 poses obtained from the docking run and the other 134 poses. The poses 
are ordered based on the cluster to which they belong. Cluster 1 includes poses 1-63, cluster 2 
includes poses 64-74, cluster 3 includes poses 75-87, cluster 4 includes poses 88-115, cluster 5 
includes poses 116-128, and cluster 6 includes poses 129-135. Each square in the figure 
represents a pair of poses as labeled on the x and y axes, and its color is an indication of the 
similarity of the poses (in percentage). As reflected in the colored matrix, the similarity of 
clusters 1-3 is rather high such that most of their members exhibit at least 60% similarity. The 
similarity between clusters 4 and 5 and between each of theses clusters and clusters 1-3 is 
significantly lower: for most pairs, the similarity is around 20-30%. Cluster 6, on the other hand 
is completely different from all other clusters, exhibiting 0% similarity with any of them. 
 
Supplemental Figure S4:  
Location of the cholesterol molecule in each of the centers of the six clusters of the potential 
cholesterol binding sites identified by the docking analysis relative to the belt of the residues that 
affect cholesterol sensitivity of the channels identified by the site-directed mutagenesis. In 
clusters 1-5, the cholesterol molecule is located between two adjacent subunits and in cluster 6, 
the cholesterol molecule is located between the four subunits of the channel. The residues that 
participate in the binding site are colored yellow, and the residues of the cholesterol sensitivity 
belt are colored red. Below each model are shown the residues that appear in the binding sites 
defined by all members of each cluster, and the percentage of poses in the cluster in which each 
residue appears. Most clusters (clusters 1-5) suggest possible binding sites at the interface 
between the cytosolic domain and the TM domain. In clusters 1-3, 5 cholesterol is almost 
parallel to the pore of the channel, partially penetrating into the cytosolic domain, and in cluster 
4, cholesterol is almost perpendicular to the pore, mostly interacting with the slide helix and the 
TM domain. Cluster 6, on the other hand, suggests a possible binding site at center of the 
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